Find your next paid study

VA Office of Research and DevelopmentNCT05157282

~$10 – $675

Actual pay is set by the research site.

Phase 2

Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes to Increase Airway L-arginine/ADMA Ratio and Improve Asthma Control

Patients with obese late onset (after childhood) asthma can have lower FeNO levels, yet be highly symptomatic and poorly responsive to inhaled steroids. This i…

AsthmaObesity

University of Colorado, DenverNCT03885245

~$75 – $2,000

Actual pay is set by the research site.

Recurrent Adult Soft Tissue Sarcoma

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractio…

Jonsson Comprehensive Cancer CenterNCT02701153

Actual pay is set by the research site.

The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care

The study is enrolling adults who are scheduled for either inpatient or outpatient elective surgical procedures at The University of Chicago. At pre-operative…

Surgery

University of ChicagoNCT03729180

Actual pay is set by the research site.

Phase 1

Neural Response to Inflammatory Challenge in Major Depressive Disorder

This is a parallel group, double-blinded, placebo-controlled study. Participants with MDD (n=90) and HC (n=90) will be randomly assigned (2:1) to receive eithe…

Major Depressive Disorder

Laureate Institute for Brain Research, Inc.NCT04751331

~$500 – $10,500

Actual pay is set by the research site.

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

This is a multi-center, prospective, observational study designed to evaluate the impact of LV myocardial fibrosis extent assessed by CMR on LV reverse remodel…

Heart Failure and Reduced Ejection FractionFunctional Mitral Regurgitation

Minneapolis Heart Institute FoundationNCT07131631

Actual pay is set by the research site.

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understandin…

Coronary; Ischemic

Genetesis Inc.NCT05868902

~$10 – $1,050

Actual pay is set by the research site.

Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients

Fibromyalgia (FM) is a syndrome with clinical symptoms involving multiple systems. The efficacy of current treatments is inadequate, and more alternative modal…

Fibromyalgia

Massachusetts General HospitalNCT06009159

Actual pay is set by the research site.

Phase 1

Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic condit…

Autoimmune DiseasesCardiovascular DisordersDiabetes Complications+8 more

Thomas Advanced Medical LLCNCT04684602

~$500 – $10,500

Actual pay is set by the research site.

ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (…

Prostate Cancer

Weill Medical College of Cornell UniversityNCT05948657

Actual pay is set by the research site.

Phase 1

(2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.

The goal of this randomized double blind three way (1:1:1) cross over clinical trial is to evaluate the effectiveness and duration of analgesia of a single inf…

Pain, Neuropathic

Rush University Medical CenterNCT05864053

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-attack Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting…

Migraine